In contrast, loss of type I IFN signaling—such as IFN-β deficiency- leads to the emergence of pro-tumoral neutrophils with impaired tumor cell killing, reduced activation marker expression, and prolonged survival that ultimately favors tumor progression and metastasis. The gene discussed is IFNB1; the disease is neoplasm.